Results 81 to 90 of about 212,880 (258)

A replication study separates polymorphisms behind migraine with and without depression

, 2021
Péter Petschner, Dániel Baksa, Gábor Hullám, Dóra Török, András Millinghoffer, J.F.W. Deakin, György Bagdy, Gabriella Juhász   +7 more
openalex   +2 more sources

Safety of Rimegepant in Adults with Migraine and Anxiety, Depression, or Using Antidepressants: Analysis of a Multicenter, Long-Term, Open-Label Study

Pain and Therapy
Introduction Anxiety and depression are frequently associated with migraine, and antidepressant use can complicate treatment. These analyses assessed the safety and tolerability of rimegepant in participants with migraine and anxiety and/or depression ...
David Kudrow, Susan Hutchinson, Glenn C. Pixton, Terence Fullerton   +3 more
doaj   +1 more source

Complications of Migraine: Migrainous Infarction

Clinical and Experimental Hypertension, 2006
Migraine and cerebrovascular disorders are comorbid diseases and the overlap of their clinical symptoms has relevant diagnostic and therapeutic implications. The prototypic condition of this relationship is reproduced by a clinical event named migrainous infarction (MI), listed by the ICHD-II among the "complication of migraine." We discuss the ...
Giorgio, Bono, Giorgio, Minonzio, Marco, Mauri, Angelo Maurizio, Clerici   +3 more
openaire   +2 more sources

Migraine and the risk of post-traumatic stress disorder among a cohort of pregnant women

The Journal of Headache and Pain, 2017
Background Individually both migraine and post-traumatic stress disorder (PTSD) prevalence estimates are higher among women. However, there is limited data on the association of migraine and PTSD in women during pregnancy.
Lauren E. Friedman, Christina Aponte, Rigoberto Perez Hernandez, Juan Carlos Velez, Bizu Gelaye, Sixto E. Sánchez, Michelle A. Williams, B. Lee Peterlin   +7 more
doaj   +1 more source

Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2019
Importance Ubrogepant is an oral calcitonin gene-related peptide receptor antagonist under investigation for acute treatment of migraine. Objective To evaluate the efficacy and tolerability of ubrogepant compared with placebo for acute treatment of a ...
R. Lipton, D. Dodick, J. Ailani, K. Lu, M. Finnegan, A. Szegedi, Joel M. Trugman   +6 more
semanticscholar   +1 more source

Dynamic brainstem and somatosensory cortical excitability during migraine cycles [PDF]

, 2022
Fu‐Jung Hsiao, Wei‐Ta Chen, Li‐Ling Hope Pan, Hung‐Yu Liu, Yen-Feng Wang, Shih‐Pin Chen, Kuan‐Lin Lai, Gianluca Coppola, Shuu‐Jiun Wang   +8 more
openalex   +1 more source

Migraine

Acta clinica Croatica, 2010
Migraine is a primary recurrent headache manifesting in attacks lasting 4-72 hours and aff ects 2-20% of world population. Women are more often aff ected, mostly during reproductive years. Th e migraine effects quality of life and has negative impact on working capability.
openaire   +3 more sources

EHMTI-0087. Use of oxicodone/naloxone extended release for menstrual migraine [PDF]

, 2014
C. Mostardini, Giovanni M. Pauletti
openalex   +1 more source

Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse

The Journal of Headache and Pain
Background Migraine is a disabling neurologic disease that can fluctuate over time in severity, frequency, and acute medication use. Harris Poll Migraine Report Card was a US population-based survey to ascertain quantifiable distinctions amongst ...
Amaal J. Starling, Roger Cady, Dawn C. Buse, Meghan Buzby, Charlie Spinale, Kathy Steinberg, Kevin Lenaburg, Steven Kymes   +7 more
doaj   +1 more source

Migraine [PDF]

European Neurology, 2005
H C, Diener, A, Eikermann, L, Pageler
openaire   +4 more sources